The relatively modest effects of PPARγ deficiencies in fat,muscle, and liver provided the impetus for broadening the analysisof Pparg KO to additional cell types that participate inobesity-associated metabolic complications, namely diabetes,hypertension, and atherosclerosis. This evidence concerns the gene PPARG and Hypertension.